Update: JNJ

I got Johnson & Johnson (JNJ) in my portfolio for a long time. First, is it a good company? Yes it is! Unlike some of the other gems in my portfolio, this stock has a bit too much debt. Based on 2016 Q3 data, the stock is undervalued, but not overly so. JNJ released 2016 Q4 data some weeks back, but google is to lazy to update their financial page. Me too;) As soon as I have the 206 Q4 numbers, I can update. But for now:

BUY AT: lower than 155 USD

SELL AT: 222 USD